CAS 33069-62-4

General Information

Derived from the Pacific yew tree, paclitaxel has therapeutic potential for a variety of cancers, including ovarian cancer, breast cancer, non-small cell lung cancer and AIDS-related Kaposi sarcoma (a type of cancer that develops under the skin). It is administered intravenously. Specific uses for paclitaxel: 1. First-line and subsequent therapy for the treatment of advanced ovarian cancer.

About the API

Technology Synthetic
Therapeutic category Oncology
Available formulations Injectables
Regulations CEP Flag CEP EU DMF Flag EU DMF US DMF Flag US DMF